Nuveen Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | $11.1M | Sell |
220,679
-1,401
| -0.6% | -$70.6K | ﹤0.01% | 1538 |
|
2024
Q3 | $10.3M | Sell |
222,080
-1,285
| -0.6% | -$59.5K | ﹤0.01% | 1584 |
|
2024
Q2 | $7.26M | Buy |
223,365
+4,328
| +2% | +$141K | ﹤0.01% | 1757 |
|
2024
Q1 | $5.52M | Sell |
219,037
-44,354
| -17% | -$1.12M | ﹤0.01% | 1939 |
|
2023
Q4 | $8.55M | Buy |
263,391
+5,011
| +2% | +$163K | ﹤0.01% | 1695 |
|
2023
Q3 | $7.04M | Sell |
258,380
-20,266
| -7% | -$552K | ﹤0.01% | 1684 |
|
2023
Q2 | $6.2M | Buy |
278,646
+31,594
| +13% | +$703K | ﹤0.01% | 1788 |
|
2023
Q1 | $5.35M | Sell |
247,052
-7,006
| -3% | -$152K | ﹤0.01% | 1848 |
|
2022
Q4 | $5.16M | Sell |
254,058
-8,986
| -3% | -$183K | ﹤0.01% | 1888 |
|
2022
Q3 | $6.74M | Sell |
263,044
-162,954
| -38% | -$4.18M | ﹤0.01% | 1714 |
|
2022
Q2 | $10.1M | Buy |
425,998
+72,237
| +20% | +$1.72M | ﹤0.01% | 1503 |
|
2022
Q1 | $8.71M | Buy |
353,761
+65,122
| +23% | +$1.6M | ﹤0.01% | 1738 |
|
2021
Q4 | $5.58M | Sell |
288,639
-51,520
| -15% | -$996K | ﹤0.01% | 2050 |
|
2021
Q3 | $6.7M | Sell |
340,159
-42,776
| -11% | -$842K | ﹤0.01% | 2060 |
|
2021
Q2 | $8.43M | Sell |
382,935
-57,467
| -13% | -$1.26M | ﹤0.01% | 1973 |
|
2021
Q1 | $10.5M | Buy |
440,402
+2,314
| +0.5% | +$55K | ﹤0.01% | 1768 |
|
2020
Q4 | $11.5M | Buy |
438,088
+410
| +0.1% | +$10.7K | ﹤0.01% | 1620 |
|
2020
Q3 | $7.62M | Sell |
437,678
-209,925
| -32% | -$3.65M | ﹤0.01% | 1682 |
|
2020
Q2 | $10.9M | Buy |
647,603
+4,468
| +0.7% | +$75.2K | ﹤0.01% | 1428 |
|
2020
Q1 | $7.65M | Buy |
643,135
+187,239
| +41% | +$2.23M | ﹤0.01% | 1458 |
|
2019
Q4 | $5.52M | Sell |
455,896
-62,262
| -12% | -$753K | ﹤0.01% | 1939 |
|
2019
Q3 | $7.32M | Sell |
518,158
-4,620
| -0.9% | -$65.3K | ﹤0.01% | 1752 |
|
2019
Q2 | $5.83M | Buy |
+522,778
| New | +$5.83M | ﹤0.01% | 1892 |
|